These results suggest that diabetic patients with comparatively low pulse pressure indicating less advanced arteriosclerosis may receive benefits of improvement in inflammatory parameters such as HMW-ADN and PAI-1 by taking candesartan. This evidence concerns the gene SERPINE1 and arteriosclerosis.